Customer Story QbD accelerates the move toward ever more innovative areas of research in pharmaceuticals It’s no surprise to anyone that medical costs continue to rise, putting important treatments out of reach for many patients around the world. Inexpensive new treatments that don’t compromise quality are a holy grail to pharmaceutical companies, with both patients and health provid- ers eager for options. T o meet this demand, pharmaceutical companies are pursuing innovative areas of research that capitalize on the availability of increasingly large amounts of medical data, such as personalized med- icine and biologics. Despite fierce competition and high research costs, the massive untapped global marketplace for these products makes the potential payoff irresistible. Rising t

Join for free to read